Immune cell therapy
免疫細胞療法(NK細胞療法など)/ Immune cell therapy
Blood is drawn, immune cells such as NK cells are cultured and multiplied, and they are returned by drip. In Japanese private practice it is offered alongside cancer treatment, and also to healthy people in the name of preventing cancer or boosting immunity.
At a glance
- Legal classification
- Class III regenerative medicine
- Source of the cells
- Your own blood
- Visits needed
- Several per course: each time blood is drawn first and infused 2–3 weeks later
- Culture time
- About 2–3 weeks
- Planning your stay
- You leave the same day each time; a course often means several trips to Japan
What it is used for
- A supplement to standard cancer treatment, at the patient's own choice
- It does not replace surgery, chemotherapy or radiotherapy
- For healthy people seeking prevention, there is no reliable supporting evidence at present
How it is done
Consultation
The physician reviews your condition and current treatment and explains the therapy and risks.
Blood draw
Blood is taken from a vein.
Culture
About 2–3 weeks at a cell processing facility.
Infusion
An intravenous drip of about 30–60 minutes.
The evidence so far
- For immune cell therapy offered as private treatment, longer survival or cancer prevention has not been confirmed
- It is not the same thing as the approved immune checkpoint inhibitors or CAR-T cell therapy
- Not covered by Japan's public health insurance
Risks
- Fever, chills and fatigue after infusion
- Infection from contaminated cells: in September 2024 two healthy adults in Japan developed sepsis and were admitted to intensive care after autologous NK cell therapy, and the health ministry issued emergency orders to the clinic and the cell processing facility
- Delaying standard treatment because of it, to the harm of the illness
- High cost, and several trips per course
Precautions
Before and after
- Tell the physician about all treatment you are receiving, and tell your own doctor about this therapy
- Seek care at once for a fever that does not settle, or chills
When it is unsuitable or needs a physician's assessment
- Active infection
- Immunosuppressant medication
- Autoimmune disease needs a physician's assessment
- Pregnancy or breastfeeding
Questions to ask at the consultation
- What is the provision plan number and what does it cover?
- Where are the cells cultured, which sterility tests are done before release, and could they be infused before results are back?
- Does my own doctor know, and could it interfere with current treatment?
- How many infusions per course, and what is the total cost?
This page is general information based on what was public as of November 2026. Suitability is for the physician to judge at the consultation. Filing a provision plan is a procedural requirement and does not mean the state has confirmed that a treatment works.